Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
David Neal Franz Department of Pediatrics, Tuberous Sclerosis Clinic, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA Abstract: Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder caused by inactivating mutations in either the TSC1 or TSC2 genes. It...
Enregistré dans:
Auteur principal: | Franz DN |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/41bc3f129b4f4366a7ce06a3cc1cc93a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
par: Cong Luo, et autres
Publié: (2021) -
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
par: Capal JK, et autres
Publié: (2016) -
Aggressive retinal astrocytoma associated with tuberous sclerosis
par: Tomida M, et autres
Publié: (2012) -
The genomic landscape of tuberous sclerosis complex
par: Katie R. Martin, et autres
Publié: (2017) -
Dermoscopy of Facial Angiofibromas in Four Patients of Skin of Color with Tuberous Sclerosis Complex: A Case-Series
par: Rashmi Jindal, et autres
Publié: (2021)